Agilent Technologies, Inc. $A Stock Holdings Cut by Journey Advisory Group LLC

Journey Advisory Group LLC cut its position in shares of Agilent Technologies, Inc. (NYSE:A) by 85.5% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 2,989 shares of the medical research company’s stock after selling 17,634 shares during the quarter. Journey Advisory Group LLC’s holdings in Agilent Technologies were worth $384,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Vanguard Group Inc. boosted its stake in Agilent Technologies by 1.8% during the second quarter. Vanguard Group Inc. now owns 33,997,845 shares of the medical research company’s stock valued at $4,012,086,000 after buying an additional 589,219 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in Agilent Technologies by 10.7% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock valued at $1,560,964,000 after acquiring an additional 1,273,994 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Agilent Technologies by 1.6% in the 2nd quarter. Geode Capital Management LLC now owns 7,319,530 shares of the medical research company’s stock valued at $860,137,000 after acquiring an additional 115,183 shares during the last quarter. Generation Investment Management LLP boosted its position in shares of Agilent Technologies by 15.9% during the 2nd quarter. Generation Investment Management LLP now owns 5,775,860 shares of the medical research company’s stock valued at $681,609,000 after purchasing an additional 792,304 shares in the last quarter. Finally, Norges Bank acquired a new position in shares of Agilent Technologies in the 2nd quarter worth approximately $395,088,000.

Analyst Upgrades and Downgrades

A has been the topic of a number of research reports. Bank of America boosted their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a report on Tuesday, November 25th. UBS Group lifted their price target on shares of Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a research report on Tuesday, November 25th. Citigroup upped their price target on Agilent Technologies from $165.00 to $185.00 and gave the company a “buy” rating in a report on Tuesday, November 25th. Evercore upgraded Agilent Technologies from an “in-line” rating to an “outperform” rating and increased their price objective for the company from $155.00 to $160.00 in a research report on Monday, January 5th. Finally, HSBC started coverage on Agilent Technologies in a report on Tuesday, January 20th. They issued a “buy” rating and a $180.00 target price on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $164.50.

Insider Activity

In related news, VP Rodney Gonsalves sold 3,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the sale, the vice president directly owned 31,846 shares in the company, valued at approximately $4,935,811.54. This trade represents a 8.61% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Agilent Technologies Trading Down 2.7%

NYSE A opened at $122.92 on Friday. The firm’s 50 day moving average price is $136.17 and its two-hundred day moving average price is $135.75. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $160.27. The stock has a market cap of $34.77 billion, a price-to-earnings ratio of 26.90, a PEG ratio of 3.57 and a beta of 1.30.

Agilent Technologies (NYSE:A) last issued its earnings results on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, topping the consensus estimate of $1.58 by $0.01. The business had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.83 billion. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.Agilent Technologies’s revenue was up 9.4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be given a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio is 22.32%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.